Shaanxi Meibang Pharmaceutical Group Co., Ltd. (605033.SS)
CNY 12.67
(-0.63%)
CNY 12.67
(-0.63%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.43 CNY | -59.81% |
| 2022 | 1.07 CNY | 15.05% |
| 2021 | 0.93 CNY | 60.34% |
| 2020 | 0.58 CNY | 3.57% |
| 2019 | 0.56 CNY | -11.11% |
| 2018 | 0.63 CNY | -7.35% |
| 2017 | 0.68 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.02 CNY | -93.3% |
| 2024 Q3 | -0.03 CNY | -238.91% |
| 2024 Q1 | 0.33 CNY | 443.04% |
| 2023 Q2 | 0.03 CNY | -93.71% |
| 2023 FY | - CNY | -59.81% |
| 2023 Q4 | -0.10 CNY | -280.24% |
| 2023 Q3 | -0.03 CNY | -178.82% |
| 2023 Q1 | 0.51 CNY | 104.0% |
| 2022 Q3 | -0.04 CNY | -120.26% |
| 2022 Q2 | 0.19 CNY | -72.06% |
| 2022 Q1 | 0.68 CNY | 47.83% |
| 2022 FY | - CNY | 15.05% |
| 2022 Q4 | 0.25 CNY | 749.35% |
| 2021 FY | - CNY | 60.34% |
| 2021 Q4 | 0.46 CNY | 900.0% |
| 2021 Q3 | -0.06 CNY | -125.0% |
| 2021 Q2 | 0.23 CNY | -50.0% |
| 2021 Q1 | 0.46 CNY | 70.37% |
| 2020 FY | - CNY | 3.57% |
| 2020 Q4 | 0.27 CNY | 307.69% |
| 2020 Q3 | -0.13 CNY | -165.0% |
| 2020 Q2 | 0.20 CNY | -53.49% |
| 2020 Q1 | 0.43 CNY | 0.0% |
| 2019 FY | - CNY | -11.11% |
| 2018 FY | - CNY | -7.35% |
| 2017 FY | - CNY | 0.0% |